Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB
Sponsor: Abeona Therapeutics, Inc
Summary
A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Official title: A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
OBSERVATIONAL
Enrollment
22
Start Date
2021-02-09
Completion Date
2036-08
Last Updated
2024-06-27
Healthy Volunteers
No
Conditions
Interventions
EB-101
This is non-interventional and follows patients treated with EB-101
Locations (2)
Stanford University
Redwood City, California, United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States